Kopran Limited has successfully concluded a Good Manufacturing Practice (GMP) inspection conducted by the European Union (EU) Medicine Authority at its formulation manufacturing facility in Khopoli. The audit, which took place from September 18 to September 23, 2026, resulted in no critical observations and no data integrity issues.

The regulatory review identified one major observation and several minor observations. Kopran stated that it is currently in the process of submitting compliance responses to the EU authorities within a fortnight. This disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Inspection outcomes

The EU GMP inspection focused on the company’s formulation manufacturing capabilities at the Khopoli site. The absence of critical findings indicates that the facility meets the fundamental quality standards required for export markets in Europe. However, the presence of one major observation suggests specific areas requiring corrective action before full compliance is certified.

What the numbers show

The inspection results highlight a strong baseline for quality compliance, evidenced by the zero count for critical and data integrity issues. For pharmaceutical exporters, data integrity is often the most stringent hurdle in EU audits; clearing this without remarks is a significant positive signal for operational robustness. The single major observation represents a manageable deviation rather than a systemic failure, allowing the company to proceed with its planned response timeline.

United Shippers Limited has disposed of a significant portion of its stake in Kopran , selling 12,00,000 equity shares through the open market. The transaction, executed on September 7, 2026, reduced the promoter group’s holding in the specialty chemicals manufacturer.

The disposal was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. United Shippers, identified as part of the promoter group, filed the disclosure with stock exchanges on September 8, 2026.

Shareholding Changes

Prior to the sale, United Shippers held 22,00,000 shares in Kopran, representing 4.56% of the total voting capital. Following the off-market transaction, its holding dropped to 10,00,000 shares, or 2.07% of the equity share capital.

The total equity share capital of Kopran remained unchanged at 4,82,85,605 equity shares before and after the transaction. No warrants, convertible securities, or voting rights other than shares were involved in the deal.

Transaction Details

The sale was conducted entirely through the open market mechanism. United Shippers confirmed that there were no encumbrances, such as pledges or liens, on the shares prior to or following the disposal. The authorized signatory for the filing was Dheraj Jajwal.